MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Bovie swings to 2011 black | Earnings Roundup

Bovie swings to 2011 black | Earnings Roundup

By

MassDevice.com Earnings Roundup

Bovie Medical swings to 2011 black
Bovie Medical (NYSE:BVX) posted losses of $876,000, or 5¢ per share, on sales of $6.2 million during the 3 months ended Dec. 31, 2011. That compares with losses of $1.4 million, or 8¢ per share, on sales of $6.2 million during the same period in 2010.

For the full year, Bovie reported profits of $109 million, or 1¢ per share, on sales of $25.4 million. That compares with losses of $1.5 million, or 9¢ per share, on sales of $24.2 million during 2010.
Read more

Cambridge Heart’s losses widen in Q4, 2011
Cambridge Heart (NSDQ:CAMH) posted losses of $1.4 million, or 1¢ per share, on sales of $557,000 during the 3 months ended Dec. 31, 2011. That compares with losses of $1.2 million, or 2¢ per share, on sales of $714,000 during the same period in 2010.

For the full year, Cambridge Heart reported losses of $5.4 million, or 5¢ per share, on sales of $2.2 million. That compares with losses of $5.2 million, or 7¢ per share, on sales of $2.8 million during 2010.
Read more

Daxor moves to 2011 red
Daxor (NYSE:DXR) posted losses of $7.2 million, or $1.70 per share, on sales of $1.4 million during the 12 months ended Dec. 31, 2011. That compares with profits of $5.0 million, or $1.17 per share, on sales of $1.6 million during 2010.
Read more

Dehaier’s Q4, 2011 profits slide
Dehaier Medical Systems (NSDQ:DHRM) posted profits of $99,000, or -1¢ per share, on sales of $5.4 million during the 3 months ended Dec. 31, 2011. That compares with profits of $1.8 million, or 32¢ per share, on sales of $6.7 million during the same period in 2010.

For the full year, Dehaier reported profits of $4.2 million, or 69¢ per share, on sales of $21.6 million. That compares with profits of $5.2 million, or $1.09 per share, on sales of $19.6 million during 2010.
Read more

Losses soar for Derma Sciences
Derma Sciences (NSDQ:DSCI) posted losses of $2.5 million, or 23¢ per share, on sales of $16.5 million during the 3 months ended Dec. 31, 2011. That compares with losses of $347,000 million, or 5¢ per share, on sales of $15.3 million during the same period in 2010.

For the full year, Derma Sciences reported losses of $4.3 million, or 49¢ per share, on sales of $62.6 million. That compares with losses of $2.4 million, or 39¢ per share, on sales of $56.5 million during 2010.
Read more

Echo Therapeutics’s 2011 losses rise
Echo Therapeutics (NSDQ:ECTE) posted losses of $16.7 million, or 49¢ per share during the 3 months ended Dec. 31, 2011. That compares with losses of $4.3 million, or 15¢ per share, during the same period in 2010.
Read more

EDAP narrows Q4, 2011 losses
EDAP (NSDQ:EDAP) posted losses of $779,000, or 6¢ per share, on sales of $10.1 million during the 3 months ended Dec. 31, 2011. That compares with losses of $9.7 million, or 74¢ per share, on sales of $10.8 million during the same period in 2010.

For the full year, EDAP reported losses of $1.3 million, or $1.10 per share, on sales of $31.2 million. That compares with losses of $16.8 million, or $1.29 per share, on sales of $30.6 million during 2010.
Read more

Sales slide, losses soar for Guided Therapeutics
Guided Therapeutics (OTC:GTHP) posted losses of $2.8 million, or 5¢ per share, on sales of $921,000 during the 3 months ended Dec. 31, 2011. That compares with losses of $280,000, or 1¢ per share, on sales of $1.1 million during the same period in 2010.

For the full year, Guided Therapeutics reported losses of $6.6 million, or 14¢ per share, on sales of $3.6 million. That compares with losses of $4.5 million, or 12¢ per share, on sales of $3.4 million during 2010.
Read more

Kips Bay Medical pares 2011 losses
Kips Bay Medical (NSDQ:KIPS) posted losses of $1.1 million, or 7¢ per share, on sales of $94,000 during the 3 months ended Dec. 31, 2011. That compares with losses of $803,000, or 6¢ per share, on sales of $116,000 during the same period in 2010.

For the full year, Kips Bay reported losses of $4.3 million, or 27¢ per share, on sales of $252,000. That compares with losses of $10.9 million, or 81¢ per share, on sales of $223,000 during 2010.
Read more

Profits plunge for Lumenis
Lumenis posted profits of $690,000, or 0¢ per share, on sales of $247.0 million during 2011. That compares with profits of $5.7 million, or 3¢ per share, on sales of $237.7 million during 2010.
Read more

Mazor Robotics boosts sales, pares Q4 losses
Mazor Robotics (PINK:MZRTF) posted losses of $1.3 million, or 6¢ per share, on sales of $1.8 million during the 3 months ended Dec. 31, 2011. That compares with losses of $1.8 million, or 7¢ per share, on sales of $1.3 million during the same period in 2010.

For the full year, Mazor reported losses of $7.8 million, or 36¢ per share, on sales of $5.8 million. That compares with losses of $6.1 million, or 32¢ per share, on sales of $4.2 million during 2010.
Read more

Sales, losses fall for Nephros
Nephros (OTC:NEPH) posted losses of $2.4 million, or 27¢ per share, on sales of $2.2 million during 2011. That compares with losses of $1.9 million, or 93¢ per share, on sales of $2.9 million during 2010.
Read more

Non Invasive Monitoring Systems halves losses, doubles sales
Non Invasive Monitoring Systems (OTC:NIMU) posted losses of $106,000, or 0¢ per share, on sales of $89,000 during 2011. That compares with losses of $311,000, also 0¢ per share, on sales of $187,000 during 2010.
Read more

Patient Safety Technologies slides to 2011 red
Patient Safety Technologies (OTC:PSTX) posted losses of $2.4 million, or 8¢ per share, on sales of $9.5 million during 2011. That compares with profits of $1.8 million, or 6¢ per share, on sales of $14.8 million during 2010.
Read more

Response Biomedical halves 2011 losses
Response Biomedical (TSE:RBM) posted losses of $5.4 million, or 14¢ per share, on sales of $9.0 million during 2011. That compares with losses of $10.1 million, or 32¢ per share, on sales of $6.8 million during 2010.
Read more

Sanuwave cuts losses
Sanuwave Health (OTC:SNWV) posted losses of $10.2 million, or 52¢ per share, on sales of $803,000 during 2011. That compares with losses of $15.2 million, or $1.15 per share, on sales of $728,000 during 2010.
Read more

Losses rise, sales fall for Stereotaxis
Stereotaxis (NSDQ:STXS) posted losses of $32.0 million, or 58¢ per share, on sales of $42.0 million during 2011. That compares with losses of $19.9 million, or 39¢ per share, on sales of $54.1 million during 2010.
Read more

Tengion’s 2011 losses rise
Tengion (NSDQ:TNGN) posted losses of $5.9 million, or 48¢ per share, during the 3 months ended Dec. 31, 2011. That compares with losses of $14.0 million, or 59¢ per share during 2010.

For the full year, Tengion reported losses of $25.6 million, or $3.22 per share, compared with losses of $19.1 million, or 88¢ per share, during 2010.
Read more

Vasomedical’s losses soar
Vasomedical (PINK:VASO) posted losses of $4.3 million, or 4¢ per share, on sales of $16.7 million during 2011. That compares with losses of $1.9 million, or 2¢ per share, on sales of $4.2 million during 2010.
Read more

Sales up, profits down for Young Innovations
Young Innovations (NSDQ:YDNT) posted profits of $16.5 million, or $2.06 per share, on sales of $106.2 million during 2011. That compares with profits of $17.9 million, or $1.87 per share, on sales of $102.8 million during 2010.
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Medical device companies put $3.6 billion in docs’ pockets, study finds
    Medtech companies paid $3.62 billion for access to physicians — 10% more than drug companies did — from 2014 to 2017, according to new research. Device company payments to surgical specialists were significantly more tied to the surgeons’ Medicare billing than payments from drug companies to specialists, according to the study, which appears in the… […]
  • FDA slaps Class I label on rapid infuser recall
    The FDA today declared that the recall of an emergency infusion device kit is the most serious type. The recall covers three models of disposable sets made by Smisson-Cartledge Biomedical for its ThermaCor 1200 rapid infuser, which is used for fluid or bolus delivery. The system is made of a footswitch for hands-free fluid control,… […]
  • Cretex breaks ground on new plant north of Minneapolis
    Cretex Cos. last week broke ground on a new 245,000 ft2 medical device contract manufacturing plant in Brooklyn Park, Minn. Elk River, Minn.–based Cretex plans to complete facility construction by the end of the year. The company expects the facility by the end of 2022 to house its stamping, molding and tool design — and… […]
  • Resonetics to expand manufacturing in Costa Rica
    Resonetics announced today it has leased new manufacturing space in Costa Rica to more than double its production there. The space, in a building near its current site in the Coyol Free Zone business park in Alajuela, will be expanded and reconfigured to create a 45,000 ft² production site. The move comes after the company… […]
  • Are Black patients not getting LVADs as quickly as white patients?
    Researchers from the University of Missouri conducted a study that found disparities in treating Black and white patients with advanced heart failure. According to a news release, the study found that Black patients with advanced heart failure were more likely to receive a left ventricular assist device (LVAD) — a pump implanted into the chest… […]
  • Viant expands factory in Costa Rica
    Viant announced today that it has completed a major expansion of its medical device manufacturing facility in Heredia, Costa Rica. The company said it invested in the additional capacity to meet market demand for minimally invasive surgical devices, including energy-based devices. Begun in fall 2020, the expansion adds 14,000 ft² of ISO Class 8 cleanroom… […]
  • St. Jude Medical founder and his Medical 21 raise $3M
    Raising money for a startup company during a pandemic is no cakewalk, according to Manny Villafaña. But he did it. Medical 21, the latest venture for the founder of St. Jude Medical, has raised another $3 million in an equity offering, according to an SEC filing. The most recent round brings the Minneapolis-based startup’s total funding… […]
  • How can patient input improve clinical trials?
    The Medical Device Innovation Consortium (MDIC) has laid out some recommendations for improving medical device clinical trials with increased patient input. Having observed that clinical trial sponsors seldom refer to patient input — something the FDA issued guidance for in September 2019 — MDIC offered its view on increasing and using patient input to improve… […]
  • Orchid names new CFO
    Orchid Orthopedic Solutions (Holt, Mich.) announced this week that Matt Tharp has joined the company as chief financial officer. Tharp comes to Orchid from Ammega, where he held the role of CFO – Americas. He has more than 20 years of experience in supply chain, operations and finance and has held leadership roles at Midwest… […]
  • ICS establishes dedicated medical device practice
    Integrated Computer Solutions (ICS) is establishing a dedicated medical device practice amid increased demand for complex medtech. ICS said its work in the medical and life sciences markets has nearly doubled year-over-year as connected technologies drive innovation and transform healthcare. “There has been extraordinary innovation and growth in the medtech sector in recent years which… […]
  • SMC is expanding its Costa Rica facility
    SMC (Somerset, Wis.) recently announced that it will double the size of its Alajuela, Costa Rica facility to 120,000 ft2 this year. The additional space will enable SMC Costa Rica to provide increased contract manufacturing solutions, including assembly, injection molding and secondary operations. SMC plans to double the number of workers it has in the Central… […]

Leave a Reply